191 related articles for article (PubMed ID: 18958175)
1. The role of alpha 6 integrin in prostate cancer migration and bone pain in a novel xenograft model.
King TE; Pawar SC; Majuta L; Sroka IC; Wynn D; Demetriou MC; Nagle RB; Porreca F; Cress AE
PLoS One; 2008; 3(10):e3535. PubMed ID: 18958175
[TBL] [Abstract][Full Text] [Related]
2. Extracellular engagement of alpha6 integrin inhibited urokinase-type plasminogen activator-mediated cleavage and delayed human prostate bone metastasis.
Ports MO; Nagle RB; Pond GD; Cress AE
Cancer Res; 2009 Jun; 69(12):5007-14. PubMed ID: 19491258
[TBL] [Abstract][Full Text] [Related]
3. Gene Editing of α6 Integrin Inhibits Muscle Invasive Networks and Increases Cell-Cell Biophysical Properties in Prostate Cancer.
Rubenstein CS; Gard JMC; Wang M; McGrath JE; Ingabire N; Hinton JP; Marr KD; Simpson SJ; Nagle RB; Miranti CK; Warfel NA; Garcia JGN; Arif-Tiwari H; Cress AE
Cancer Res; 2019 Sep; 79(18):4703-4714. PubMed ID: 31337652
[TBL] [Abstract][Full Text] [Related]
4. Integrin alpha6 cleavage: a novel modification to modulate cell migration.
Pawar SC; Demetriou MC; Nagle RB; Bowden GT; Cress AE
Exp Cell Res; 2007 Apr; 313(6):1080-9. PubMed ID: 17303120
[TBL] [Abstract][Full Text] [Related]
5. alpha6 integrin cleavage: sensitizing human prostate cancer to ionizing radiation.
Pawar SC; Dougherty S; Pennington ME; Demetriou MC; Stea BD; Dorr RT; Cress AE
Int J Radiat Biol; 2007; 83(11-12):761-7. PubMed ID: 18058365
[TBL] [Abstract][Full Text] [Related]
6. Intracellular modifiers of integrin alpha 6p production in aggressive prostate and breast cancer cell lines.
Kacsinta AD; Rubenstein CS; Sroka IC; Pawar S; Gard JM; Nagle RB; Cress AE
Biochem Biophys Res Commun; 2014 Nov; 454(2):335-40. PubMed ID: 25450398
[TBL] [Abstract][Full Text] [Related]
7. Extracellular alpha 6 integrin cleavage by urokinase-type plasminogen activator in human prostate cancer.
Demetriou MC; Pennington ME; Nagle RB; Cress AE
Exp Cell Res; 2004 Apr; 294(2):550-8. PubMed ID: 15023541
[TBL] [Abstract][Full Text] [Related]
8. Targeting ECM-integrin interaction with liposome-encapsulated small interfering RNAs inhibits the growth of human prostate cancer in a bone xenograft imaging model.
Bisanz K; Yu J; Edlund M; Spohn B; Hung MC; Chung LW; Hsieh CL
Mol Ther; 2005 Oct; 12(4):634-43. PubMed ID: 16039164
[TBL] [Abstract][Full Text] [Related]
9. Schwann Cells Increase Prostate and Pancreatic Tumor Cell Invasion Using Laminin Binding A6 Integrin.
Sroka IC; Chopra H; Das L; Gard JM; Nagle RB; Cress AE
J Cell Biochem; 2016 Feb; 117(2):491-9. PubMed ID: 26239765
[TBL] [Abstract][Full Text] [Related]
10. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML
Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511
[TBL] [Abstract][Full Text] [Related]
11. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
[TBL] [Abstract][Full Text] [Related]
12. Integrin alpha 6 expression in human prostate carcinoma cells is associated with a migratory and invasive phenotype in vitro and in vivo.
Rabinovitz I; Nagle RB; Cress AE
Clin Exp Metastasis; 1995 Nov; 13(6):481-91. PubMed ID: 7586806
[TBL] [Abstract][Full Text] [Related]
13. Site-specific S-nitrosylation of integrin α6 increases the extent of prostate cancer cell migration by enhancing integrin β1 association and weakening adherence to laminin-1.
Isaac J; Tarapore P; Zhang X; Lam YW; Ho SM
Biochemistry; 2012 Dec; 51(48):9689-97. PubMed ID: 23106339
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer specific integrin alphavbeta3 modulates bone metastatic growth and tissue remodeling.
McCabe NP; De S; Vasanji A; Brainard J; Byzova TV
Oncogene; 2007 Sep; 26(42):6238-43. PubMed ID: 17369840
[TBL] [Abstract][Full Text] [Related]
15. Analysis of integrin alpha7 mutations in prostate cancer, liver cancer, glioblastoma multiforme, and leiomyosarcoma.
Ren B; Yu YP; Tseng GC; Wu C; Chen K; Rao UN; Nelson J; Michalopoulos GK; Luo JH
J Natl Cancer Inst; 2007 Jun; 99(11):868-80. PubMed ID: 17551147
[TBL] [Abstract][Full Text] [Related]
16. Targeting integrin α6 stimulates curative-type bone metastasis lesions in a xenograft model.
Landowski TH; Gard J; Pond E; Pond GD; Nagle RB; Geffre CP; Cress AE
Mol Cancer Ther; 2014 Jun; 13(6):1558-66. PubMed ID: 24739392
[TBL] [Abstract][Full Text] [Related]
17. Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis.
Cher ML; Biliran HR; Bhagat S; Meng Y; Che M; Lockett J; Abrams J; Fridman R; Zachareas M; Sheng S
Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7847-52. PubMed ID: 12788977
[TBL] [Abstract][Full Text] [Related]
18. Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment.
Ahmed N; Riley C; Rice G; Quinn M
Clin Exp Metastasis; 2005; 22(5):391-402. PubMed ID: 16283482
[TBL] [Abstract][Full Text] [Related]
19. RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes.
Armstrong AP; Miller RE; Jones JC; Zhang J; Keller ET; Dougall WC
Prostate; 2008 Jan; 68(1):92-104. PubMed ID: 18008334
[TBL] [Abstract][Full Text] [Related]
20. Discoidin domain receptor 2 facilitates prostate cancer bone metastasis via regulating parathyroid hormone-related protein.
Yan Z; Jin S; Wei Z; Huilian H; Zhanhai Y; Yue T; Juan L; Jing L; Libo Y; Xu L
Biochim Biophys Acta; 2014 Sep; 1842(9):1350-63. PubMed ID: 24787381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]